• Ogilvie, Gina


    Investigator, BC Children's Hospital
    Physician, BC Women's Hospital and Health Centre
    Professor, School of Population and Public Health, University of British Columbia
    Assistant Director, Women's Health Research Institute 
    Senior Public Health Scientist, BC Centre for Disease Control

    Degrees / Designations

    MD, MSc, FCFP, DrPH

    Primary Area of Research
    Healthy Starts
    Secondary Area(s) of Research
    Global Health & Innovation
    604-875-2424 ext. 6488
    Lab Phone
    Mailing Address

    Room H203G
    BC Women's Hospital and Health Centre
    4500 Oak Street
    Vancouver, BC V6H 3N1

    Affiliate Websites
    Research Areas

    Human papilloma virus, cervical cancer, sexually transmitted infections, women's health, global health, HIV, gynecology


    Gina Ogilvie, MD MSc FCFP DrPH is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at the University of British Columbia in the School of Population and Public Health. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre. 

    Dr. Ogilvie is currently principal investigator on over $13-million in research grants and she has received funding from PHAC, CIHR, Michael Smith Foundation for Health Research, Canadian Foundation for Innovation and private foundations including BC Women’s Hospital Foundation among others.

    Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally. 

    She has published over 100 peer reviewed manuscripts and has provided advice and consultation to national and global institutions, including the Canadian Partnership Against Cancer, Public Health Agency of Canada, the World Health Organization and Ministries of Health globally on STI, HIV and HPV vaccine policy and programming.

    She speaks widely at international and national research and education conferences, and has supervised medical students, residents, and graduate students throughout her career.

    Current Projects

    Among other research projects, she is principal investigator for the ASPIRE program, a global health initiative conducting research and providing women-centred, innovative solutions for cervical cancer prevention and reproductive health in sub-Saharan Africa.  She also leads HPV FOCAL, which is a randomized trial of over 25,000 women comparing primary screening for cervical cancer, and QUEST, a pragmatic randomized trial defining the effectiveness of reduced dosing of the HPV vaccine.

    Selected Publications

    Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, et al. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. Tropical medicine & international health 2015; 20(10):1355-67. PMID: 26031572

    Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. 2013; 309(17):1793-802. PMID: 23632723

    Ogilvie GS, van Niekerk DJ, Krajden M, Martin RE, Ehlen TG, et al. A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC cancer. 2010; 10:111 PMID: 20334685

    Cook DA, Smith LW, Law J, Mei W, van Niekerk DJ, Ceballos K, Gondara L, Franco EL, Coldman AJ, Ogilvie GS, Jang D, Chernesky M, Krajden M. Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial. J Clin Virol. 2016 Dec 11 PMID: 27988420 

    Mitchell SM, Pedersen HN, Eng Stime E, Sekikubo M, Moses E, Mwesigwa D, Biryabarema C, Christilaw J, Byamugisha JK, Money DM, Ogilvie GS. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity. BMC Womens Health. 2017 Jan 13 PMID: 28086933

    Perez S, Tatar O, Shapiro GK, Dubé E, Ogilvie G, Guichon J, Gilca V, Rosberger Z. Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study. BMC Public Health. 2016 Dec 5 PMID: 27919239 

    Coldman AJ, Gondara L, Smith LW, van Niekerk D, Ceballos K, Krajden M, Cook D, Quinlan DJ, Lee M, Stuart GC, Peacock S, Martin RE, Gentile L, Franco EL, Ogilvie GS. Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialBr J Cancer. 2016 Dec 6;115(12):1487-1494. doi: 10.1038/bjc.2016.368. PubMed PMID: 27855441.



    CIHR Foundation Scheme Integrated global control of HPV related disease and cancer     2015-2022

    Michael Smith Foundation for Health Research Quadrivalent vaccine evaluation study (QUEST) 2012-2024

    CIHR A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening   2007-2016 

    Honours & Awards

    Canada Research Chair, Tier I “Global control of HPV related disease and cancer” April 2015-April 2022
    Recipient, Researcher of the Year for BC Chapter of Family Physicians, College of Family Physicians of Canada, July 2014
    Recipient, Distinguished Achievement Award, Applied or Clinical Research, Faculty of Medicine, University of British Columbia 

    Research Group Members

    Darlene Taylor
    Laurie Smith
    Darrel Cook
    Gordean Bjornson
    Jamie Forest
    Virginia Russell
    Alex Mezei